Loading…

Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy (在非增殖性糖尿病视网膜病变中的氧化剂、抗氧化剂以及线粒体功能)

Background Diabetic retinopathy (DR) is a preventable cause of visual disability. The aims of the present study were to investigate levels and behavior oxidative stress markers and mitochondrial function in non‐proliferative DR (NPDR) and to establish the correlation between the severity of NPDR and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes 2014-03, Vol.6 (2), p.167-175
Main Authors: Rodríguez-Carrizalez, Adolfo Daniel, Castellanos-González, José Alberto, Martínez-Romero, Esaú César, Miller-Arrevillaga, Guillermo, Villa-Hernández, David, Hernández-Godínez, Pedro Pablo, Ortiz, Genaro Gabriel, Pacheco-Moisés, Fermín Paul, Cardona-Muñoz, Ernesto Germán, Miranda-Díaz, Alejandra Guillermina
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Diabetic retinopathy (DR) is a preventable cause of visual disability. The aims of the present study were to investigate levels and behavior oxidative stress markers and mitochondrial function in non‐proliferative DR (NPDR) and to establish the correlation between the severity of NPDR and markers of oxidative stress and mitochondrial function. Methods In a transverse analysis, type 2 diabetes mellitus (T2DM) patients with mild, moderate and severe non‐proliferative DR (NPDR) were evaluated for markers of oxidative stress (i.e. products of lipid peroxidation (LPO) and nitric oxide (NO) catabolites) and antioxidant activity (i.e. total antioxidant capacity (TAC), catalase, and glutathione peroxidase (GPx) activity of erythrocytes). Mitochondrial function was also determined as the fluidity of the submitochondrial particles of platelets and the hydrolytic activity of F0/F1‐ATPase. Results Levels of LPO and NO were significantly increased in T2DM patients with severe NPDR (3.19 ± 0.05 μmol/mL and 45.62 ± 1.27 pmol/mL, respectively; P 
ISSN:1753-0393
1753-0407
DOI:10.1111/1753-0407.12076